teresag Posted October 22, 2003 Share Posted October 22, 2003 "Gefitinib, a well-tolerated oral EGFR-tyrosine kinase inhibitor, improved disease-related symptoms and induced radiographic tumor regressions in patients with NSCLC persisting after chemotherapy. " Abstract can be read here: http://jama.ama-assn.org/cgi/content/abstract/290/16/2149 Quote Link to comment Share on other sites More sharing options...
Margaret Posted October 28, 2003 Share Posted October 28, 2003 Thanks for posting that, Teresa. Actually, Dr. Ronald Natale is my oncologist at Cedars-Sinai. Margaret Quote Link to comment Share on other sites More sharing options...
Bob.Durham Posted November 2, 2003 Share Posted November 2, 2003 Hi Teresa: Thanks for posting this - as it happens, Dr. Barth at Hoag has recommended a combination of of gefitinib in conjunction with cisplatin and docetaxel. Deb has been doing this since mid September - I am trying to find supporting citations & research to justify this with our insurance folks but have had no success to date - the closest I have found so far is some work by Frances A. Shepherd, MD at Princess Margaret Hospital in Toronto who spoke at The 3rd Princess Margaret Hospital Conference on New Developments in Cancer Management in September, 2003... Thanks again, Bob Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.